Characterizing and monitoring the glycan population of a biotherapeutic protein has continued to present technical and logistical challenges to the biopharmaceutical industry. Improvements to analytical technologies and informatics have made the process quicker and more automated, but overall laboratory workflows for released glycan analysis have continued to be laborious and require high skill to generate accurate and reproducible profiles.
In our talk at WCBP 2015, we introduce a new solution: GlycoWorks RapiFluor MS labeling reagent, which enables use of FLR and MS for glycan monitoring and characterization.
Download a pdf of the talk below, or watch a video of our talk:
Title | Format | File Size |
---|---|---|
wcbp_2015_rapifluorms_and_glycan_workflows | 5042.06kB |